NO163327C - Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.

Info

Publication number
NO163327C
NO163327C NO831806A NO831806A NO163327C NO 163327 C NO163327 C NO 163327C NO 831806 A NO831806 A NO 831806A NO 831806 A NO831806 A NO 831806A NO 163327 C NO163327 C NO 163327C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogue procedure
dihydropyridines
active dihydropyridines
Prior art date
Application number
NO831806A
Other languages
English (en)
Norwegian (no)
Other versions
NO163327B (no
NO831806L (no
Inventor
Peder Bernhard Berntsson
Stig Aake Ingemar Carlsson
Bengt Richard Ljung
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NO831806L publication Critical patent/NO831806L/no
Priority to NO881824A priority Critical patent/NO167455C/no
Publication of NO163327B publication Critical patent/NO163327B/no
Publication of NO163327C publication Critical patent/NO163327C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO831806A 1982-05-21 1983-05-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner. NO163327C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO881824A NO167455C (no) 1982-05-21 1988-04-26 Mellomprodukter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8203176 1982-05-21

Publications (3)

Publication Number Publication Date
NO831806L NO831806L (no) 1983-11-22
NO163327B NO163327B (no) 1990-01-29
NO163327C true NO163327C (no) 1990-05-09

Family

ID=20346867

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831806A NO163327C (no) 1982-05-21 1983-05-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.

Country Status (19)

Country Link
EP (1) EP0095451A3 (da)
JP (1) JPS58210063A (da)
KR (1) KR900006682B1 (da)
AU (1) AU1464583A (da)
CA (1) CA1205471A (da)
DD (2) DD209816A5 (da)
DK (1) DK223683A (da)
ES (3) ES8503655A1 (da)
FI (1) FI80677C (da)
GB (1) GB2120668B (da)
GR (1) GR78566B (da)
HU (2) HU188342B (da)
IL (1) IL68524A0 (da)
IS (1) IS1381B6 (da)
MW (1) MW1783A1 (da)
NO (1) NO163327C (da)
NZ (1) NZ204283A (da)
PT (1) PT76733B (da)
ZA (1) ZA833112B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3600594A1 (de) * 1986-01-11 1987-07-16 Bayer Ag Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung
US4814455A (en) * 1986-04-16 1989-03-21 Bristol-Myers Company Dihydro-3,5-dicarboxylates
JPS63112560A (ja) * 1986-10-29 1988-05-17 Green Cross Corp:The ジヒドロピリジン誘導体
US5310917A (en) * 1991-09-13 1994-05-10 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropydrines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
EP0002007B1 (de) * 1977-11-11 1982-07-28 Ciba-Geigy Ag Neue Pyridindicarbonsäureesterderivate und ihre Gemische mit metallhaltigen Stabilisatoren sowie ihre Verwendung zur Stabilisierung von chlorhaltigen Thermoplasten
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids

Also Published As

Publication number Publication date
ZA833112B (en) 1983-12-28
HU188342B (en) 1986-04-28
GB8314034D0 (en) 1983-06-29
PT76733B (en) 1986-03-27
ES535216A0 (es) 1985-05-01
GB2120668B (en) 1985-08-29
CA1205471A (en) 1986-06-03
ES8504713A1 (es) 1985-05-01
FI831778L (fi) 1983-11-22
MW1783A1 (en) 1985-06-12
GB2120668A (en) 1983-12-07
FI80677C (fi) 1990-07-10
FI831778A0 (fi) 1983-05-19
IL68524A0 (en) 1983-07-31
PT76733A (en) 1983-06-01
HU193786B (en) 1987-11-30
KR900006682B1 (ko) 1990-09-17
EP0095451A2 (en) 1983-11-30
GR78566B (da) 1984-09-27
FI80677B (fi) 1990-03-30
DK223683A (da) 1983-11-22
EP0095451A3 (en) 1984-08-29
IS1381B6 (is) 1989-08-28
DD209816A5 (de) 1984-05-23
JPS58210063A (ja) 1983-12-07
ES522570A0 (es) 1985-03-16
NO163327B (no) 1990-01-29
DD216009A5 (de) 1984-11-28
NZ204283A (en) 1985-11-08
KR840004723A (ko) 1984-10-24
NO831806L (no) 1983-11-22
IS2809A7 (is) 1983-11-22
ES8504712A1 (es) 1985-05-01
DK223683D0 (da) 1983-05-19
ES8503655A1 (es) 1985-03-16
ES535215A0 (es) 1985-05-01
AU1464583A (en) 1983-11-24

Similar Documents

Publication Publication Date Title
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO160850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO812344L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider.
NO165027C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO164295C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO873680L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO157618C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamid-inderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.